Cancer cells cheat suicide call

Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of...

Coordination of world-class research facilities

Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and...

Mingling types - who to aim for and who to avoid:

Read about different mingling types - who are you?

Spara vatten och minska avfallet

Att tillverka den bästa produkten till ett konkurrenskraftigt pris är en utmaning. Spara vatten och minska avfallet med ett piggingsystem från DEFINOX.

Brittisk forskning hamnar efter

Mindre finansiering får Storbritanniens forskning att tappa mark, enligt organisationen Case.

Plenadren säljs vidare

Duocort Pharmas preparat tas upp i irländska Shires portfölj med specialläkemedel.

Astra-nej får blandat mottagande av aktieägarna

Efter att Astrazenecas ledning tackat nej till Pfizers budpropåer för fjärde gången har missnöje väckts hos några av aktieägarna.

Nya standarder för effektiv utveckling

- För effektivare läkemedelsutveckling

A smart company takes care of its best

Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.

Bio-Linux goes global

Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

She is Sweden´s new Minister of Healthcare

Today, Tuesday, Swedish Prime Minister Ulf Kristersson, who leads the Moderate Party and the centre-right coalition in Sweden, presented the government's new mi...

Pfizer höjer budet på Astrazeneca

Pfizer beskriver det nya budet, på 607 kronor aktien, som det "sista", men räknar inte med att Astrazenecas styrelse kommer att acceptera erbjudandet.

Dako appoints new CEO

The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.

Budar på Sobi

Läkemedelsbolaget mottog nyligen ett bud från en ospecificerad budgivare.

A world-class research village

Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life sci...

Time to save for survival

The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.

Early stage research and low turnaround dominates

Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performer...

Noxious parasite forms hybrids and deceives the immune system

The small parasite Trypanosoma cruzi has a nasty ability to cause serious illness. Researchers at the Karolinska Institutet have now mapped its ability to decei...

How to get the most out of the fair

Forskare får hjälp att fatta beslut

En ny mjukvara ska samla in och tolka resultat från kliniska prövningar.

Studie: Önsketänkande kan ha väglett beteende under pandemin

En ny doktorsavhandling tyder på att vi systematiskt underskattar hälsorisker – om och när det passar oss. Det gällde inte minst under pandemin då våra riskbedö...

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

Neanderthal genes and Nobel Prize in a popular lecture at Bioscience

An inherited gene variant from our ”evolutionary cousins” – the extinct Neanderthals – may affect how our bodies break down certain drugs. “It’s only a matter o...